Cardiac monitoring devices
Mar 02, 2023
Eko’s AI-powered Sensora Platform; SOPHiA GENETICS and QIAGEN Announced Partnership; Co-Diagnostics’s At-Home and Point-of-Care Co-Dx PCR Home™ Platform; Abbott’s Minimally Invasive Heart Devices Updates; SpectraWAVE’s HyperVue™ Intravascular Imaging System; FDA Approval to Bioelectronic Medicine’s Bioelectric Technology
AI-powered Sensora Platform Launched by Eko for Cardiac Disease Detection On February 23, 2023, Eko, a digital healthcare company employing artificial intelligence (AI) against heart and lung disease, announced the launch of its SENSORA™ Cardiac Disease Detection Platform. The stethoscope, one of the m...
Read More...
Aug 18, 2022
CereVasc’s eShunt System Study; FDA Approves NGS-Based CDx for Trastuzumab Deruxtecan; Nanopath Secures $10 Million Funding; BD, Accelerate Diagnostics Announce Collaboration; Avails Medical’s Clinical Trials for eQUANT; Movano Ring Exceeds Accuracy Targets for SpO2 & Heart Rate Monitoring
CereVasc Announces FDA Approval of Second IDE Study of the eShunt® System On August 09, 2022, CereVasc, Inc., a privately held, clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, announced that the U.S. Food and Drug Administration (FDA) has approved ...
Read More...
Jan 31, 2022
Rising Global Prevalence of Cardiovascular Diseases And Top Players In Cardiology
Cardiovascular Diseases (CVDs), primarily constituting heart failure, ischemic heart disease, stroke, are considered as leading global cause of mortality and a major contributor to disability. Over the last 30 years, deaths and disabilities from Cardiovascular Disease have been steadily rising across the globe. Car...
Read More...
Jul 12, 2021
With advancements in Innovative Technology, Cardiac Monitoring Devices Market is Booming Significantly
Cardiac monitoring devices are important for cardiovascular care, to assess the occurrence and seriousness of cardiac failure and to evaluate the success of therapies such as medications, procedures, and device implants. Cardiovascular diseases (CVDs) are a global cause of death, which can be prevented. In most cas...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
